Literature DB >> 1878312

Effects of consumption of ethanol on the biological monitoring of exposure to organic solvent vapours: a simulation study with trichloroethylene.

A Sato1, K Endoh, T Kaneko, G Johanson.   

Abstract

This study illustrates possible influences of consumption of ethanol on the pharmacokinetic behaviour of inhaled trichloroethylene (TRI) in relation to biological monitoring of exposure. The results were obtained for a standard male worker of 70 kg by physiologically based pharmacokinetic modelling. Depending on the pattern of consumption of ethanol, enzyme inhibition or induction was assumed to prevail in this worker. The inhibition and induction were modelled by assuming competitive metabolic interaction between TRI and ethanol and increased maximum velocity (Vmax) of TRI metabolism respectively. Ingestion of moderate amounts of ethanol before the start of work or at lunch time, but not at the end of work, caused pronounced increases in blood TRI concentrations and decreases in the urinary excretion rates of TRI metabolites, this effect lasting until the next day. The effects were smaller the higher the exposure concentration of TRI. Induction of TRI metabolism, supposedly by consumption of ethanol the previous evening, caused only small changes in the pharmacokinetic profile at 50 ppm, but appreciable changes at 500 ppm.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878312      PMCID: PMC1035417          DOI: 10.1136/oem.48.8.548

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  21 in total

1.  Metabolism and caloric value of alcohol.

Authors:  W W WESTERFELD; M P SCHULMAN
Journal:  J Am Med Assoc       Date:  1959-05-09

2.  [A physiologically based pharmacokinetic model to describe the transfer of organic solvents in the human body. Simulation of kinetic behavior of trichloroethylene using a spreadsheet program].

Authors:  K Endoh; T Kaneko; A Sato
Journal:  Sangyo Igaku       Date:  1989-09

3.  Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man.

Authors:  A Koizumi
Journal:  Br J Ind Med       Date:  1989-04

Review 4.  Pharmacokinetics of organic solvent vapors in relation to their toxicity.

Authors:  A Sato; T Nakajima
Journal:  Scand J Work Environ Health       Date:  1987-04       Impact factor: 5.024

5.  The P450 gene superfamily: recommended nomenclature.

Authors:  D W Nebert; M Adesnik; M J Coon; R W Estabrook; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson; B Kemper; W Levin
Journal:  DNA       Date:  1987-02

6.  Metabolism of trichloroethylene in man. III. Interaction of trichloroethylene and ethanol.

Authors:  G Müller; M Spassowski; D Henschler
Journal:  Arch Toxicol       Date:  1975       Impact factor: 5.153

7.  Acetone-inducible cytochrome P-450: purification, catalytic activity, and interaction with cytochrome b5.

Authors:  C J Patten; S M Ning; A Y Lu; C S Yang
Journal:  Arch Biochem Biophys       Date:  1986-12       Impact factor: 4.013

8.  The effects of ethanol on the kinetics of toluene in man.

Authors:  M Wallén; P H Näslund; M B Nordqvist
Journal:  Toxicol Appl Pharmacol       Date:  1984-12       Impact factor: 4.219

9.  Enhanced metabolism of volatile hydrocarbons in rat liver following food deprivation, restricted carbohydrate intake, and administration of ethanol, phenobarbital, polychlorinated biphenyl and 3-methylcholanthrene: a comparative study.

Authors:  A Sato; T Nakajima
Journal:  Xenobiotica       Date:  1985-01       Impact factor: 1.908

10.  Effect of ethanol, cimetidine and propranolol on toluene metabolism in man.

Authors:  M Døssing; J Baelum; S H Hansen; G R Lundqvist
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

View more
  11 in total

1.  A human PBPK model for ethanol describing inhibition of gastric motility.

Authors:  George D Loizou; Martin Spendiff
Journal:  J Mol Histol       Date:  2004-09       Impact factor: 2.611

2.  Effects of smoking and drinking on excretion of hippuric acid among toluene-exposed workers.

Authors:  O Inoue; K Seiji; T Watanabe; H Nakatsuka; C Jin; S J Liu; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

3.  Enzyme induction by ethanol consumption affects the pharmacokinetics of inhaled m-xylene only at high levels of exposure.

Authors:  T Kaneko; P Y Wang; A Sato
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

4.  Confounding factors in biological monitoring of exposure to organic solvents.

Authors:  A Sato
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

5.  Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. II. 1,1,1-Trichloroethane and trichloroethylene.

Authors:  S Laparé; R Tardif; J Brodeur
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

6.  Ethanol induced modification of m-xylene toxicokinetics in humans.

Authors:  R Tardif; A Sato; S Laparé; J Brodeur
Journal:  Occup Environ Med       Date:  1994-03       Impact factor: 4.402

7.  Some critical issues and concerns related to research advances on toxicology of chemical mixtures.

Authors:  R S Yang
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

Review 8.  Physiologically based pharmacokinetic analyses of simple mixtures.

Authors:  K Krishnan; H J Clewell; M E Andersen
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

Review 9.  Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.

Authors:  R S Yang; R S Thomas; D L Gustafson; J Campain; S A Benjamin; H J Verhaar; M M Mumtaz
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

Review 10.  Human variability and susceptibility to trichloroethylene.

Authors:  G M Pastino; W Y Yap; M Carroquino
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.